| 1 |
25712361 |
Drug resistance of clinical varicella-zoster virus strains confirmed by recombinant thymidine kinase expression and by targeted resistance mutagenesis of a cloned wild-type isolate |
Mutation
|
| 2 |
21345964 |
Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE/gI heterodimer formation, gI structure, and virulence in skin cells |
Mutation
|
| 3 |
16971426 |
ORF66 protein kinase function is required for T-cell tropism of varicella-zoster virus in vivo |
Mutation
|
| 4 |
9624615 |
Acyclovir-resistant varicella-zoster virus: phenotypic and genetic characterization |
Mutation
|
| 5 |
21539861 |
Resistance testing of clinical varicella-zoster virus strains |
Mutation
|
| 6 |
28886462 |
Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades |
Mutation
|
| 7 |
16905355 |
A novel varicella-zoster virus gE mutation discovered in two Swedish isolates |
Mutation
|
| 8 |
39353981 |
Preliminary investigation and analysis of nucleotide site variability of nine glycoproteins on varicella-zoster virus envelope, Jilin Province, China, 2010-March 2024 |
Mutation
|
| 9 |
19474103 |
Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo |
Mutation
|
| 10 |
22176950 |
Sequencing and characterization of Varicella-zoster virus vaccine strain SuduVax |
Mutation
|
| 11 |
34960186 |
Effects of Varicella-Zoster Virus Glycoprotein E Carboxyl-Terminal Mutation on mRNA Vaccine Efficacy |
Mutation
|
| 12 |
7486953 |
Analysis of mutations in the thymidine kinase gene of varicella zoster virus associated with resistance to 5-iodo-2'-deoxyuridine and 5-bromo-2'-deoxyuridine |
Mutation
|
Overview of VZV associated (Mutation)
